References
- Wolfe F: The clinical syndrome of fibrositis. Am J Med 81 (suppl 3A) 7–14, 1986.
- Morrow JD, Schroeder HA, Perry HM Jr: Studies in the control of hyperten-sion by Hyphex H. Toxic reactions and side effects. Circulation 8:829–839, 1953.
- Hess EV, Mongey A: Drug related lupus. Bull Rheum Dis. Vol 40; No. 4, 1–8, 1991.
- Solinger, AM: Drug related lupus; clinical and etiological considerations. Rheum. dis. clin. North Am, Vol. 14, No. 1, 187–201, 1989.
- Lee SL, Chase PH: Drug-induced systemic lupus erythematosus: A critical review. Semin. Arthritis and Rheum., Vol. 5, No. 1, 83–97, 1975.
- Carpenter JR, McDuffie PC, Sheps LR, Spiekerman RE, Brumfield H, King R: Prospective study of immune response to hydralazine and development of anti-deoxyribonucleoptrotien inpatients receiving hydralazine Am J Med 69, 395–400, 1980.
- Wolfe F, Smythe HA, Yunus MB et al: The American College of Rheu-matology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. Vol. 33, 160–172, 1990.
- Bennet RM: Confounding features of the fibromyalgia syndrome; A cur-rent perspective of differential diagnosis. J. Rheumatol suppl No. 19, Nov. 19, Vol. 16, 58–61, 1986.
- Yunus MB, Masi AT Aldag JC: Short term effects of ibuprofen in primary fibromyalgia syndrome: A double blind placebo controlled trial. J Rheumatol 16: 527–532, 1989.
- Buckelew SP: Fibromyalgia: A rehabilitation approach. Am. J Phys. Med Rehabil, February, Vol. 68, No. 1, 37–42, 1989.